ImmunityBio Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	0.62	0.24	0.93	0.61	2.2	0.05	0.05	0.04	0.24	0.64	Upgrade
Revenue Growth (YoY)	159.17%	-74.30%	54.38%	-72.52%	4585.11%	4.44%	2.27%	-81.36%	-63.18%	6.83%	Upgrade
Gross Profit	0.62	0.24	0.93	0.61	2.2	0.05	0.05	0.04	0.24	0.64	Upgrade
Selling, General & Admin	129.62	102.71	135.26	71.32	46.46	42.72	57.12	95.39	227.68	4.62	Upgrade
Research & Development	232.37	248.15	195.96	139.51	112	55.72	42.04	29.15	11.43	1.6	Upgrade
Other Operating Expenses	0.89	0.68	0	10.66	0	0	0	0	0	0	Upgrade
Operating Expenses	362.87	351.54	331.21	221.49	158.45	98.44	99.17	124.54	239.11	6.22	Upgrade
Operating Income	-362.25	-351.3	-330.28	-220.88	-156.25	-98.39	-99.12	-124.5	-238.88	-5.58	Upgrade
Interest Expense / Income	129.2	63.52	14.85	9.07	5.92	0.43	0.62	0.07	0	0.47	Upgrade
Other Expense / Income	91.79	1.72	1.65	-6.26	-4.29	-2.09	-2.82	-3.19	-1.7	0.14	Upgrade
Pretax Income	-583.24	-416.53	-346.78	-223.7	-157.88	-96.73	-96.92	-121.38	-237.18	-6.18	Upgrade
Income Tax	-0.04	0.03	0.01	-1.85	-0.11	-0.5	-0.49	-0.57	-0.3	0	Upgrade
Net Income	-583.2	-416.57	-346.79	-221.85	-157.78	-96.23	-96.42	-120.81	-236.88	-6.19	Upgrade
Shares Outstanding (Basic)	509	400	389	377	366	79	81	82	72	8	Upgrade
Shares Outstanding (Diluted)	509	400	389	377	366	79	81	82	72	8	Upgrade
Shares Change	27.19%	2.74%	3.23%	2.93%	362.93%	-1.80%	-1.70%	14.62%	767.32%	934.50%	Upgrade
EPS (Basic)	-1.15	-1.04	-0.89	-0.59	-0.43	-1.22	-1.20	-1.47	-3.31	-0.75	Upgrade
EPS (Diluted)	-1.15	-1.04	-0.89	-0.59	-0.43	-1.22	-1.20	-1.47	-3.31	-0.75	Upgrade
Free Cash Flow	-397.34	-415.67	-287.48	-173.39	-156.2	-76.07	-83.6	-45.15	-27.55	-5.65	Upgrade
Free Cash Flow Per Share	-0.78	-1.04	-0.74	-0.46	-0.43	-0.96	-1.04	-0.55	-0.39	-0.69	Upgrade
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-58239.55%	-146374.17%	-35361.88%	-36509.09%	-7095.87%	-209338.30%	-220266.67%	-282954.55%	-101218.64%	-869.73%	Upgrade
Profit Margin	-93761.41%	-173569.58%	-37129.55%	-36669.59%	-7165.17%	-204736.17%	-214273.33%	-274565.91%	-100371.19%	-964.90%	Upgrade
Free Cash Flow Margin	-63881.19%	-173196.25%	-30779.87%	-28660.00%	-7093.37%	-161853.19%	-185766.67%	-102620.45%	-11672.03%	-881.90%	Upgrade
EBITDA	-429.41	-328.83	-312.81	-196.73	-133.79	-86.74	-90.73	-117.71	-235.71	-5.68	Upgrade
EBITDA Margin	-69037.62%	-137010.83%	-33491.43%	-32517.19%	-6075.79%	-184555.32%	-201626.67%	-267518.18%	-99875.00%	-885.65%	Upgrade
Depreciation & Amortization	24.62	24.19	19.12	17.89	18.17	9.56	5.57	3.61	1.47	0.04	Upgrade
EBIT	-454.04	-353.02	-331.93	-214.62	-151.96	-96.3	-96.3	-121.32	-237.18	-5.71	Upgrade
EBIT Margin	-72996.46%	-147090.83%	-35538.76%	-35474.88%	-6901.09%	-204885.11%	-213995.56%	-275715.91%	-100498.73%	-891.26%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).